by The Angiogenesis Foundation | Nov 26, 2014 | Uncategorized
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved aflibercept (EYLEA®) Injection for diabetic macular edema (DME). EYLEA has already been approved in Japan for the treatment of patients with neovascular age-related macular degeneration (wet AMD),...
by The Angiogenesis Foundation | May 7, 2013 | Uncategorized
CAMBRIDGE, Ma., May 7, 2013 – The Angiogenesis Foundation released a white paper that addresses the barriers faced by individuals in the Asia-Pacific region in seeking effective treatment for wet Age-Related Macular Degeneration (AMD), the second-leading cause of...
